Juyoung (Ju) Ha currently serves as a Senior Medical Safety Lead at Novartis, a position they have held since 2025. Prior to this role, they were an Associate Clinical Safety Director at Roche from 2023 to 2025 and held various positions in pharmacovigilance, including Associate Director of Patient Safety TA Oncology at AstraZeneca and Pharmacovigilance Manager at Regulis Consulting Ltd (Pharmalex) from 2020 to 2021. Juyoung also worked as a Global Pharmacovigilance Associate at Celltrion Inc. and as a Principal Safety Scientist at GSK between 2019 and 2020. They began their academic journey at the University of Oxford, where they are currently pursuing a Master of Science in Experimental and Translational Therapeutics.
This person is not in the org chart
This person is not in any offices